Cystic fibrosis

被引：0

作者：

不详

机构：

[1] Department of Paediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität, Berlin

[2] German Centre for Lung Research (DZL), Associated Partner Site Berlin, Berlin

[3] German Center for Child and Adolescent Health (DZKJ), Partner Site Berlin, Berlin

[4] Université Paris Cité and Institut Cochin, Inserm U1016, Paris

[5] Department of Respiratory Medicine and National Reference Center for Cystic Fibrosis, Cochin Hospital, Assistance Publique Hôpitaux de Paris (AP-HP), Paris

[6] IRCCS Istituto Giannina Gaslini, Cystic Fibrosis Center, Genoa

[7] Lung Institute, Imperial College London, London

[8] St Thomas’ NHS Trust, London

[9] St Thomas’ Trust, London

[10] Department of Internal Medicine, University of Kansas Medical Center, Kansas City, MO

[11] Division of Pulmonary, Critical Care and Sleep Medicine, National Jewish Health, Denver, CO

[12] Division of Pulmonary Sciences and Critical Care Medicine, Anschutz Medical Campus, University of Colorado, Aurora, CO

[13] Division of Paediatric Pulmonary Medicine, National Jewish Health, Denver, CO

来源：

NATURE REVIEWS DISEASE PRIMERS | 2024年 / 10卷 / 01期

基金：

美国国家卫生研究院;

关键词：

D O I：

10.1038/s41572-024-00545-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This PrimeView highlights the mechanisms of cystic fibrosis and summarizes the epidemiology, diagnosis, management and outlook of this disorder. It accompanies the Primer article on this topic by Mall et al.

引用

页数：1

共 349 条

[71] Alterations in lipids after initiation of highly effective modulators in people with cystic fibrosis [J].

Despotes, Katherine A. ;

Ceppe, Agathe S. ;

Donaldson, Scott H. .

JOURNAL OF CYSTIC FIBROSIS, 2023, 22 (06) :1024-1026

[72] Qualitative and quantitative evaluation of computed tomography changes in adults with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor: a retrospective observational study [J].

Dettmer, Sabine ;

Weinheimer, Oliver ;

Sauer-Heilborn, Annette ;

Lammers, Oliver ;

Wielpuetz, Mark O. ;

Fuge, Jan ;

Welte, Tobias ;

Wacker, Frank ;

Ringshausen, Felix C. .

FRONTIERS IN PHARMACOLOGY, 2023, 14

[73] Effect of highly effective modulator therapy on quality of life in adults with cystic fibrosis [J].

DiMango, Emily ;

Spielman, Daniel B. ;

Overdevest, Jonathan ;

Keating, Claire ;

Francis, Sarah Fracasso ;

Dansky, David ;

Gudis, David A. .

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2021, 11 (01) :75-78

[74] Telemedicine and cystic fibrosis: Do we still need face-to-face clinics? [J].

Dixon, E. ;

Dick, K. ;

Ollosson, S. ;

Jones, D. ;

Mattock, H. ;

Bentley, S. ;

Saunders, C. ;

Matthews, J. ;

Dobra, B. ;

King, J. ;

Edmondson, C. ;

Davies, J. C. .

PAEDIATRIC RESPIRATORY REVIEWS, 2022, 42 :23-28

[75] The effect of discontinuing hypertonic saline or dornase alfa on mucociliary clearance in elexacaftor/tezacaftor/ivacaftor treated people with cystic fibrosis: The SIMPLIFY-MCC Study [J].

Donaldson, Scott H. ;

Corcoran, Timothy E. ;

Pilewski, Joseph M. ;

Laube, Beth L. ;

Mogayzel, Peter ;

Ceppe, Agathe ;

Wu, Jihong ;

Zeman, Kirby ;

Rowe, Steven M. ;

Nichols, David P. ;

Gifford, Alex H. ;

Bennett, William D. ;

Mayer-Hamblett, Nicole .

JOURNAL OF CYSTIC FIBROSIS, 2024, 23 (03) :457-460

[76]

Donaldson Scott H, 2007, Proc Am Thorac Soc, V4, P399, DOI 10.1513/pats.200703-042BR

[77] Effect of elexacaftor/tezacaftor/ivacaftor on mucus and mucociliary clearance in cystic fibrosis [J].

Donaldson, Scott H. ;

Corcoran, Timothy E. ;

Pilewski, Joseph M. ;

Mogayzel, Peter ;

Laube, Beth L. ;

Boitet, Evan R. ;

Harris, Elex S. ;

Ceppe, Agathe ;

Edwards, Lloyd J. ;

Zeman, Kirby ;

Wu, Jihong ;

Esther, Charles R. ;

Nichols, David P. ;

Bennett, William D. ;

Rowe, Steven M. .

JOURNAL OF CYSTIC FIBROSIS, 2024, 23 (01) :155-160

[78] Regulation of the epithelial sodium channel by serine proteases in human airways [J].

Donaldson, SH ;

Hirsh, A ;

Li, DC ;

Holloway, G ;

Chao, J ;

Boucher, RC ;

Gabriel, SE .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (10) :8338-8345

[79] Theratyping cystic fibrosis patients to guide elexacaftor/ tezacaftor/ivacaftor out-of-label prescription [J].

Dreano, Elise ;

Burgel, Pierre Regis ;

Hatton, Aurelie ;

Bouazza, Naim ;

Chevalier, Benoit ;

Macey, Julie ;

Leroy, Sylvie ;

Durieu, Isabelle ;

Weiss, Laurence ;

Grenet, Dominique ;

Stremler, Nathalie ;

Ohlmann, Camille ;

Reix, Philippe ;

Porzio, Michele ;

Claude, Pauline Roux ;

Remus, Natacha ;

Douvry, Benoit ;

Montcouquiol, Sylvie ;

Cosson, Laure ;

Mankikian, Julie ;

Languepin, Jeanne ;

Houdouin, Veronique ;

Le Clainche, Laurence ;

Guillaumot, Anne ;

Pouradier, Delphine ;

Tissot, Adrien ;

Priou, Pascaline ;

Mely, Laurent ;

Chedevergne, Frederique ;

Lebourgeois, Muriel ;

Lebihan, Jean ;

Martin, Clemence ;

Zavala, Flora ;

Da Silva, Jennifer ;

Lemonnier, Lydie ;

Kelly-Aubert, Mairead ;

Golec, Anita ;

Foucaud, Pierre ;

Marguet, Christophe ;

Edelman, Aleksander ;

Hinzpeter, Alexandre ;

de Carli, Paola ;

Girodon, Emmanuelle ;

Sermet-Gaudelus, Isabelle ;

Pranke, Iwona .

EUROPEAN RESPIRATORY JOURNAL, 2023, 62 (04)

[80] New concepts in antimicrobial resistance in cystic fibrosis respiratory infections [J].

Drevinek, Pavel ;

Canton, Rafael ;

Johansen, Helle Krogh ;

Hoffman, Lucas ;

Coenye, Tom ;

Burgel, Pierre-Regis ;

Davies, Jane C. .

JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (06) :937-945

← 3 4 5 6 7 8 9 10 11 12 →